• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞病毒 (CMV) 在日本献血者中的血清流行率和老年献血者中 CMV DNA 的高检出率。

Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors.

机构信息

Blood Service Headquarters, Japanese Red Cross, Tokyo, Japan.

出版信息

Transfusion. 2013 Oct;53(10):2190-7. doi: 10.1111/trf.12390. Epub 2013 Aug 22.

DOI:10.1111/trf.12390
PMID:23968359
Abstract

BACKGROUND

The current prevalence of cytomegalovirus (CMV) in Japan and the risk of CMV transfusion transmission are unknown in the era of seronegative leukoreduced blood components.

STUDY DESIGN AND METHODS

We measured CMV-specific immunoglobulin (Ig)M and IgG in 2400 samples of whole blood collected from 12 groups of blood donors categorized by sex and age at 10-year intervals from their teens to their 60s. We also tested for CMV DNA using polymerase chain reaction in the cellular fractions of all samples.

RESULTS

We found that 76.6% of blood donors were CMV seropositive. The seroprevalences among donors in their 20s and 30s were 58.3 and 73.3%, respectively. We detected CMV DNA in the cellular fraction of 4.3% of samples from donors in their 60s and in 1.0% of samples from donors younger than 60 years. None of the 562 seronegative samples was DNA positive. Furthermore, 14% of DNA-positive samples also contained DNA in the plasma fraction, and two of five such samples were derived from donors in their 60s. Leukoreduced plasma components derived from donations with CMV DNA in plasma samples also contained a relevant amount of CMV DNA.

CONCLUSION

The seroprevalence of CMV among Japanese blood donors of child-bearing age has not changed over the past 15 years. Latent CMV becomes reactivated more frequently among elderly donors than among younger donors. A proportion of them have free CMV DNA in their plasma fraction, which could not be diminished by leukoreduction. The risk of transfusion-transmitted CMV infection in blood with plasma CMV DNA should be determined.

摘要

背景

在目前的负血清反应白细胞减少的血液成分时代,日本巨细胞病毒(CMV)的流行情况以及 CMV 输血传播的风险尚不清楚。

研究设计和方法

我们测量了 2400 份全血样本中的 CMV 特异性免疫球蛋白(Ig)M 和 IgG,这些样本来自 12 组献血者,按性别和年龄分类,每隔 10 年从十几岁到 60 多岁进行分组。我们还使用聚合酶链反应(PCR)对所有样本的细胞部分进行了 CMV DNA 检测。

结果

我们发现,76.6%的献血者为 CMV 血清阳性。20 多岁和 30 多岁献血者的血清阳性率分别为 58.3%和 73.3%。我们在 60 多岁献血者的细胞部分样本中检测到 4.3%的 CMV DNA,在 60 岁以下献血者的样本中检测到 1.0%的 CMV DNA。在 562 份阴性血清样本中均未检测到 DNA 阳性。此外,14%的 DNA 阳性样本也含有血浆部分的 DNA,其中 5 份中有 2 份来自 60 多岁的献血者。来自含有血浆样本中 CMV DNA 的捐赠者的白细胞减少的血浆成分也含有一定量的 CMV DNA。

结论

在过去的 15 年中,日本育龄期献血者的 CMV 血清阳性率没有变化。潜伏的 CMV 在老年献血者中比年轻献血者更频繁地重新激活。他们中的一部分人在血浆部分有游离的 CMV DNA,白细胞减少并不能减少其含量。应该确定具有血浆 CMV DNA 的血液的输血传播 CMV 感染风险。

相似文献

1
Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors.巨细胞病毒 (CMV) 在日本献血者中的血清流行率和老年献血者中 CMV DNA 的高检出率。
Transfusion. 2013 Oct;53(10):2190-7. doi: 10.1111/trf.12390. Epub 2013 Aug 22.
2
High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.献血者血浆样本中巨细胞病毒DNA的高流行率与血清转化有关。
Transfusion. 2007 Nov;47(11):1972-83. doi: 10.1111/j.1537-2995.2007.01420.x.
3
The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.供者巨细胞病毒 DNA 对高危患者输血策略的影响。
Transfusion. 2013 Oct;53(10):2183-9. doi: 10.1111/trf.12199. Epub 2013 Apr 15.
4
Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.原发巨细胞病毒感染期间的窗口期献血与输血传播感染的风险。
Transfusion. 2013 May;53(5):1088-94. doi: 10.1111/trf.12074. Epub 2013 Jan 16.
5
Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.印度德里自愿献血者中巨细胞病毒的血清流行率。
J Health Popul Nutr. 2002 Dec;20(4):348-51.
6
Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME).去白细胞血液制品传播未检测抗巨细胞病毒抗体的巨细胞病毒感染:高危患者行异基因造血干细胞移植(CME)的单中心前瞻性研究。
Transfusion. 2011 Dec;51(12):2620-6. doi: 10.1111/j.1537-2995.2011.03203.x. Epub 2011 Jun 3.
7
Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.匈牙利实体器官捐献者中巨细胞病毒血清阳性率:与年龄、性别和血型的相关性
Transplant Proc. 2011 May;43(4):1233-5. doi: 10.1016/j.transproceed.2011.03.067.
8
Seroprevalence of cytomegalovirus antibodies among blood donors and Multitransfused recipients--a study from north India.献血者和多次输血受血者中巨细胞病毒抗体的血清流行率——一项来自印度北部的研究。
Transfus Apher Sci. 2014 Jun;50(3):438-42. doi: 10.1016/j.transci.2014.02.022. Epub 2014 Mar 12.
9
Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.经输血传播的巨细胞病毒:血液成分处理过程中游离病毒的行为。对瑞士不稳定血液成分安全性的研究。
Blood Transfus. 2020 Nov;18(6):446-453. doi: 10.2450/2020.0241-19. Epub 2020 Feb 28.
10
Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.巨细胞病毒阴性献血者血清对巨细胞病毒临床分离株抗原的识别。
Transfusion. 2004 Jul;44(7):1059-66. doi: 10.1111/j.1537-2995.2004.03292.x.

引用本文的文献

1
Cytomegalovirus Corneal Endotheliitis Presenting As Bullous Keratopathy: Resolution With Antiviral Therapy Alone.表现为大泡性角膜病变的巨细胞病毒性角膜内皮炎:仅抗病毒治疗即可消退
Cureus. 2025 May 15;17(5):e84175. doi: 10.7759/cureus.84175. eCollection 2025 May.
2
Incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression: the VINTAGE study.免疫抑制现代 era 中肾移植后巨细胞病毒感染的发生率:VINTAGE 研究
Ren Fail. 2025 Dec;47(1):2491658. doi: 10.1080/0886022X.2025.2491658. Epub 2025 Apr 22.
3
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT.
在非亲缘异基因造血细胞移植中,根据供者巨细胞病毒血清学状态的不同,供者年龄和人类白细胞抗原错配对造血细胞移植结果的影响也有所不同。
Blood Adv. 2025 May 13;9(9):2356-2365. doi: 10.1182/bloodadvances.2024014408.
4
The effect of infectious diseases on lung transplantation in Japan.传染病对日本肺移植的影响。
J Thorac Dis. 2024 Feb 29;16(2):1632-1644. doi: 10.21037/jtd-22-1884. Epub 2024 Feb 27.
5
CMV Infection Post Allogeneic Hematopoietic Stem Cell Transplantation in a Resource Limited Country.资源有限国家中异基因造血干细胞移植后的巨细胞病毒感染
Indian J Hematol Blood Transfus. 2024 Jan;40(1):97-102. doi: 10.1007/s12288-023-01655-0. Epub 2023 Apr 20.
6
Safety, Tolerability, and Immunogenicity of V160, a Conditionally Replication-Defective Cytomegalovirus Vaccine, in Healthy Japanese Men in a Randomized, Controlled Phase 1 Study.V160(一种条件性复制缺陷型巨细胞病毒疫苗)在健康日本男性中的安全性、耐受性和免疫原性:一项随机对照1期研究
Antibodies (Basel). 2023 Mar 10;12(1):22. doi: 10.3390/antib12010022.
7
Predictive Factors of Cytomegalovirus Viremia during the Clinical Course of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Single Center Observational Study.抗中性粒细胞胞浆抗体(ANCA)相关血管炎临床病程中巨细胞病毒血症的预测因素:一项单中心观察性研究
J Clin Med. 2023 Jan 2;12(1):351. doi: 10.3390/jcm12010351.
8
HCMV carriage in the elderly diminishes anti-viral functionality of the adaptive immune response resulting in virus replication at peripheral sites.在老年人中,CMV 携带会降低适应性免疫反应的抗病毒功能,导致病毒在外周部位复制。
Front Immunol. 2022 Dec 15;13:1083230. doi: 10.3389/fimmu.2022.1083230. eCollection 2022.
9
Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease.巨细胞病毒(CMV)pp65 抗原血症在预测风湿性疾病免疫抑制治疗期间 CMV 感染中的临床意义。
Rheumatol Int. 2023 Jun;43(6):1093-1099. doi: 10.1007/s00296-022-05196-z. Epub 2022 Aug 30.
10
Acute cytomegalovirus infection in a 61-year-old woman.一名61岁女性的急性巨细胞病毒感染。
CMAJ. 2022 Aug 22;194(32):E1109-E1111. doi: 10.1503/cmaj.220042.